Bioabsorbable Therapeutics, Inc. (BTI) was founded in 2004 to develop and commercialize the next generation of medical devices for treating vascular disease. BTI utilizes novel, proprietary anti-inflammatory polymers to create fully bioabsorbable coatings and stents. Headquartered in Northern California, BTI has development projects for both coronary vascular disease and peripheral vascular disease.

For investigational use only. Not approved for sale.